NZ223989A - Contraceptive compositions comprising melatonin and a progestogen or an estrogen or both - Google Patents

Contraceptive compositions comprising melatonin and a progestogen or an estrogen or both

Info

Publication number
NZ223989A
NZ223989A NZ223989A NZ22398988A NZ223989A NZ 223989 A NZ223989 A NZ 223989A NZ 223989 A NZ223989 A NZ 223989A NZ 22398988 A NZ22398988 A NZ 22398988A NZ 223989 A NZ223989 A NZ 223989A
Authority
NZ
New Zealand
Prior art keywords
melatonin
progestogen
estrogen
contraceptive compositions
contraceptive
Prior art date
Application number
NZ223989A
Other languages
English (en)
Inventor
Michael Cohen
Original Assignee
Applied Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Med Res filed Critical Applied Med Res
Publication of NZ223989A publication Critical patent/NZ223989A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
NZ223989A 1987-03-23 1988-03-23 Contraceptive compositions comprising melatonin and a progestogen or an estrogen or both NZ223989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/029,229 US4855305A (en) 1987-03-23 1987-03-23 Compositions and methods of effecting contraception utilizing melatonin

Publications (1)

Publication Number Publication Date
NZ223989A true NZ223989A (en) 1991-08-27

Family

ID=21847942

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ223989A NZ223989A (en) 1987-03-23 1988-03-23 Contraceptive compositions comprising melatonin and a progestogen or an estrogen or both

Country Status (26)

Country Link
US (1) US4855305A (cg-RX-API-DMAC10.html)
EP (1) EP0354921B1 (cg-RX-API-DMAC10.html)
JP (2) JP2965160B2 (cg-RX-API-DMAC10.html)
KR (1) KR890700349A (cg-RX-API-DMAC10.html)
CN (1) CN1041383C (cg-RX-API-DMAC10.html)
AT (1) ATE143807T1 (cg-RX-API-DMAC10.html)
AU (3) AU628784B2 (cg-RX-API-DMAC10.html)
BG (1) BG51075A1 (cg-RX-API-DMAC10.html)
BR (1) BR8807426A (cg-RX-API-DMAC10.html)
CA (1) CA1322527C (cg-RX-API-DMAC10.html)
DD (1) DD269557A5 (cg-RX-API-DMAC10.html)
DE (1) DE3855606T2 (cg-RX-API-DMAC10.html)
EG (1) EG18583A (cg-RX-API-DMAC10.html)
ES (1) ES2009251A6 (cg-RX-API-DMAC10.html)
FI (1) FI894423A0 (cg-RX-API-DMAC10.html)
GR (1) GR1002146B (cg-RX-API-DMAC10.html)
HU (1) HU208487B (cg-RX-API-DMAC10.html)
IL (1) IL85814A (cg-RX-API-DMAC10.html)
IN (1) IN166946B (cg-RX-API-DMAC10.html)
NZ (1) NZ223989A (cg-RX-API-DMAC10.html)
OA (1) OA09134A (cg-RX-API-DMAC10.html)
PH (1) PH26709A (cg-RX-API-DMAC10.html)
PT (1) PT87053B (cg-RX-API-DMAC10.html)
RU (1) RU2114621C1 (cg-RX-API-DMAC10.html)
WO (1) WO1988007370A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA882079B (cg-RX-API-DMAC10.html)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001395B (el) * 1987-03-23 1993-10-29 Michael Cohen Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.
EP0300630A3 (en) * 1987-07-03 1990-03-28 Schering Agrochemicals Limited Melatonin for regulating animal reproduction
IL87574A0 (en) * 1987-08-28 1989-01-31 Regulin Ltd Composition for regulating animal reproduction containing an indole derivative
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
GR900100024A (el) * 1989-01-17 1991-06-07 Amr Int Μέθοδος θεραπείας του προεμμηνορροϊκού συνδρόμου.
IN170311B (cg-RX-API-DMAC10.html) * 1989-01-17 1992-03-14 Cohen Michael
AU644367B2 (en) * 1989-05-17 1993-12-09 Applied Medical Research Ltd Use of melatonin derivatives for effecting contraception
NZ233697A (en) * 1989-05-17 1996-12-20 Applied Med Res Ltd Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen
IT1243193B (it) * 1990-08-10 1994-05-24 Medea Res Srl Composizioni farmaceutiche orali a base di melatonina
ES2082959T3 (es) * 1990-09-28 1996-04-01 I F L O S A S Di Giorgio E Ald Procedimiento para desarrollar la sintesis de una droga contraceptiva y de control del ciclo menstrual que tiene propiedades anticinetosicas, oncostaticas y terapeuticas para el tratamiento de los tumores de mama y melanomas.
DK0518468T3 (da) * 1991-05-09 2000-01-31 Neurim Pharma 1991 Melatoninholdige sammensætninger
PT100973A (pt) * 1991-10-18 1994-06-30 Alza Corp Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
IL105240A (en) * 1992-04-07 1999-04-11 Neurim Pharma 1991 The use of melatonin in the preparation of a drug for the treatment of benign prostatic hyperplasia
US6403631B1 (en) 1995-11-24 2002-06-11 Equitech Laboratories, Inc. Method and compositions for enhancing pregnancy success in an animal
US5792785A (en) * 1995-11-24 1998-08-11 Equitech Laboratories, Inc. Method for enhancing pregnancy success in an animal
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6620836B1 (en) * 1997-01-22 2003-09-16 Jay Patrick Antiarrhythmic and tranquilizer composition and treatment
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
RU2215540C2 (ru) 1997-11-14 2003-11-10 Акцо Нобель Н.В. Схемы приема гестаген-антигестагена
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
KR100861603B1 (ko) * 2000-08-30 2008-10-07 유니메드 파마슈티칼스, 엘엘씨 발기부전의 치료 및 남성의 리비도를 증가시키는 방법
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
AU2003230644A1 (en) * 2002-03-14 2003-09-29 Ercole L. Cavalieri A unifying mechanism and methods to prevent cancer and neurodegenerative diseases
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
EP1622623A4 (en) * 2003-04-11 2009-03-18 Barr Lab Inc METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED
DK1663197T3 (da) 2003-09-09 2008-01-07 Fumapharm Ag Anvendelse af fumarsyrederivater til behandling af hjerteinsuffiens og astma
BRPI0511569A (pt) * 2004-05-26 2008-01-02 Wyeth Corp composições e métodos para o tratamento de distúrbio disfórico pré-menstrual
ES2582942T3 (es) 2004-10-08 2016-09-16 Forward Pharma A/S Composiciones farmacéuticas de liberación controlada que comprenden un éster de ácido fumárico
NO346660B1 (no) 2005-10-12 2022-11-21 Unimed Pharmaceuticals Llc Forbedret testosterongel og fremgangsmåte til anvendelse
EP2068695A2 (en) * 2006-09-13 2009-06-17 Koninklijke Philips Electronics N.V. Device for automatic adjustment of the dose of melatonin and/or delivery of melatonin
SI2653873T1 (sl) 2007-02-08 2022-09-30 Biogen Ma Inc. Sestave in načini uporabe za zdravljenje multiple skleroze
DE102008036825A1 (de) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Schwangerschaftsvermeidung durch Gestagene
FR2937862B1 (fr) * 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
WO2015144965A1 (es) * 2014-03-27 2015-10-01 Servicio Andaluz De Salud Preparación duradera de inyectable de melatonina estable a largo plazo
RU2617518C2 (ru) * 2015-07-01 2017-04-25 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения и контрацепции самок млекопитающих
RU2616252C2 (ru) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения самцов млекопитающих

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
EP0004770B1 (en) * 1978-04-11 1984-06-13 Efamol Limited Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
AU5626786A (en) * 1985-03-04 1986-09-24 Cellena (Cell Engineering) A.G. Melatonin compositions and uses thereof
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors

Also Published As

Publication number Publication date
AU8693891A (en) 1991-12-19
AU1683088A (en) 1988-11-02
AU628784B2 (en) 1992-09-24
EG18583A (en) 1993-06-30
ATE143807T1 (de) 1996-10-15
GR880100177A (el) 1989-01-31
US4855305A (en) 1989-08-08
GR1002146B (en) 1996-02-19
BG51075A1 (en) 1993-02-15
IL85814A (en) 1992-05-25
HU208487B (en) 1993-11-29
KR890700349A (ko) 1989-04-24
WO1988007370A1 (en) 1988-10-06
PT87053A (pt) 1989-03-30
OA09134A (en) 1991-10-31
RU2114621C1 (ru) 1998-07-10
AU676523B2 (en) 1997-03-13
IN166946B (cg-RX-API-DMAC10.html) 1990-08-11
EP0354921B1 (en) 1996-10-09
FI894423L (fi) 1989-09-19
FI894423A7 (fi) 1989-09-19
DD269557A5 (de) 1989-07-05
EP0354921A4 (en) 1991-08-07
EP0354921A1 (en) 1990-02-21
ZA882079B (en) 1988-09-15
CN1041383C (zh) 1998-12-30
CA1322527C (en) 1993-09-28
CN88101379A (zh) 1988-10-05
FI894423A0 (fi) 1989-09-19
IL85814A0 (en) 1990-02-09
BR8807426A (pt) 1990-04-10
DE3855606D1 (de) 1996-11-14
PH26709A (en) 1992-09-15
PT87053B (pt) 1993-09-30
HUT52954A (en) 1990-09-28
ES2009251A6 (es) 1989-09-16
JPH1171276A (ja) 1999-03-16
JPH02502724A (ja) 1990-08-30
AU5513494A (en) 1994-04-14
DE3855606T2 (de) 1997-02-13
JP2965160B2 (ja) 1999-10-18

Similar Documents

Publication Publication Date Title
NZ223989A (en) Contraceptive compositions comprising melatonin and a progestogen or an estrogen or both
PL323729A1 (en) Skin sticking plaster and method of administering sole 17-deacetyl norgestimate or together with estrogen
SG55093G (en) Combination dosage form for premenopausal women
IL92069A0 (en) Contraception system and method
AU560487B2 (en) Contraceptive comprising gestodene and ethinylestradiol
NZ503890A (en) Oral contraceptives comprising non-uterotrophic anti-estrogens and progestin
CA2056364A1 (en) Compositions and methods of effecting contraception
GR900100369A (en) Contraception compositions and methods
IT1243978B (it) Farmaco per uso umano, ad azione contraccettiva ed oncostatica preventiva, nei tumori del seno, dell'utero e nel melanoma.